Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers engineer virus that blocks common genetic defect

19.09.2002


Scientists for the first time have engineered a harmless virus to correct, rather than replace, the genetic defect causing the most common single gene disorder.



The new research presents a novel approach to gene therapy in treating the most common inherited anemias: the thalassemias. Thalassemias are genetic blood diseases that result in failure to produce sufficient hemoglobin, the oxygen-carrying protein component of blood cells. This failure is caused by defects in the genetic code responsible for the production of this protein.

Scientists have explored gene therapy for these disorders for more than 20 years; only recently has this area seen a glimmer of hope. The report from the University of North Carolina at Chapel Hill is slated to appear in the Dec. 15 issue of Blood, the journal of the American Society of Hematology, and is currently online at www.bloodjournal.org.


"This research offers a new way to treat the thalassemias, by blocking a deleterious process that causes several forms of the disease," said senior study author Dr. Ryszard Kole, professor of pharmacology, and a member of UNC Lineberger Comprehensive Cancer Center and the curriculum in genetics and molecular biology at the UNC School of Medicine.

The thalassemias are caused by a variety of different mutations in the globin gene, many of which adversely affect a process known as RNA splicing.

Three billion bases - molecules that constitute DNA - form the human genome. Only a small percentage actually code for the gene products necessary for existence. These small coding regions are like words that make sense in a long continuous string of gibberish, which must be spliced out to create a meaningful message that can then be read to make the corresponding protein. Short sequences at the border between the sense and nonsense regions, called splice sites, tell the splicing machinery where to cut, where to paste and what information can be disregarded.

Some mutations can affect splicing by creating additional splice sites in places where they should not occur. Even though the correct splice sites are still intact, the splicing machinery preferentially recognizes the incorrect splice sites, resulting in the inclusion of extra, noncoding sequences, which interfere with subsequent production of hemoglobin. Kole and colleagues found that using molecules designed to bind specific regions of RNA to block aberrant splice sites could prevent splicing machinery from using those sites.

With the aberrant sites blocked, the splicing machinery goes back to the original, correct splice sites and uses these to cut and paste the correct globin message.

"In our approach the defect in the RNA is ’masked,’ thereby effectively ’repaired.’ This is different from replacing the gene with a good copy, which will then produce additional RNA and hemoglobin," Kole said. "Since we only repair the existing RNA, we do not need to worry that too much of the good thing will be made. This can sometimes be harmful."

In collaboration with Dr. Tal Kafri, co-senior author of the study, assistant professor of microbiology and immunology and a member of the Gene Therapy Center, the antisense sequences were incorporated into a lentiviral vector.

"Lentiviral vectors appear to be the most attractive vehicles to carry therapeutic genes into non-dividing target cells such as the hematopoietic stem cells," Kafri said. "Gene delivery into these cells allows us to reconstitute a patient’s bone marrow with vector-corrected stem cells that confer a lifelong remedy. The use of antisense technology coupled with these lentiviral vectors allows us to propel this field forward in the treatment of hematopoietic disorders."

In the UNC study, the genetically modified lentiviral vector was used to treat blood cells obtained from a thalassemic patient. The treatment partially restored correct splicing in the cells and resulted in a marked increase in correct hemoglobin protein. "The results are very encouraging because even hemoglobin levels that reach less than 50 percent of normal can have a therapeutically relevant effect," said Kole.

The antisense technology explored in this study is not limited to thalassemia. The finding that the human genome comprises far fewer genes than previously thought suggests that the complexity of human beings must arise from mechanisms of gene regulation, such as splicing. According to current estimates, at least 60 percent of the human genes may be alternatively spliced.

"We have been successful in the laboratory in shifting the aberrant splicing of a few other genes involved in genetic disorders and cancer," said Kole. "With the discovery that thousands of genes are spliced, as far as potential targets for this new form of gene therapy are concerned, the sky’s the limit."

Along with Kole and Kafri, UNC co-authors include Marla M. Vacek, first author of the study and a doctoral student in the curriculum in genetics and molecular biology, and Hong Ma, a researcher in the Gene Therapy Center.

Leslie Lang | EurekAlert!
Further information:
http://www.bloodjournal.org/papbyrecent.shtml.

More articles from Health and Medicine:

nachricht Infants later diagnosed with autism follow adults’ gaze, but seldom initiate joint attention
24.05.2019 | Schwedischer Forschungsrat - The Swedish Research Council

nachricht When wheels and heads are spinning - DFG research project on motion sickness in automated driving
22.05.2019 | Technische Universität Berlin

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New studies increase confidence in NASA's measure of Earth's temperature

A new assessment of NASA's record of global temperatures revealed that the agency's estimate of Earth's long-term temperature rise in recent decades is accurate to within less than a tenth of a degree Fahrenheit, providing confidence that past and future research is correctly capturing rising surface temperatures.

The most complete assessment ever of statistical uncertainty within the GISS Surface Temperature Analysis (GISTEMP) data product shows that the annual values...

Im Focus: The geometry of an electron determined for the first time

Physicists at the University of Basel are able to show for the first time how a single electron looks in an artificial atom. A newly developed method enables them to show the probability of an electron being present in a space. This allows improved control of electron spins, which could serve as the smallest information unit in a future quantum computer. The experiments were published in Physical Review Letters and the related theory in Physical Review B.

The spin of an electron is a promising candidate for use as the smallest information unit (qubit) of a quantum computer. Controlling and switching this spin or...

Im Focus: Self-repairing batteries

UTokyo engineers develop a way to create high-capacity long-life batteries

Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...

Im Focus: Quantum Cloud Computing with Self-Check

With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.

Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...

Im Focus: Accelerating quantum technologies with materials processing at the atomic scale

'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.

However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

On Mars, sands shift to a different drum

24.05.2019 | Physics and Astronomy

Piedmont Atlanta first in Georgia to offer new minimally invasive treatment for emphysema

24.05.2019 | Medical Engineering

Chemical juggling with three particles

24.05.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>